AVEO Oncology to Present at Jefferies 2015 Global Healthcare Conference

Press Release

View printer-friendly version

<<  Back

AVEO Oncology to Present at Jefferies 2015 Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 29, 2015-- AVEO Oncology (NASDAQ:AVEO) today announced that Michael P. Bailey, president and chief executive officer, will present at the Jefferies 2015 Global Healthcare Conference on Thursday, June 4, 2015 at 8:00 AM (ET) in New York City.

A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at www.aveooncology.com. A replay of the webcast will be archived for 30 days following the presentation date.

About AVEO

AVEO Oncology (AVEO) is a biopharmaceutical company committed to developing targeted therapies through biomarker-driven insights to provide improvements in patient outcomes where significant unmet medical needs exist. AVEO’s proprietary Human Response Platform™ has delivered unique insights into cancer and related disease biology that AVEO is seeking to leverage in the clinical development strategy of its therapeutic candidates. For more information, please visit the Company’s website at www.aveooncology.com.

Source: AVEO Oncology

Company, Media and Investors:
Argot Partners
David Pitts, 212-600-1902
aveo@argotpartners.com